Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

New medical device for brain monitoring at the bedside

Monday, 18 September 2017

Shieak Tzeng
Associate Professor Shieak Tzeng, Director of the Centre for Translational Physiology

A University of Otago, Wellington (UOW) team has been awarded an MBIE Endeavour grant this week to develop a non-invasive and cost-effective device to diagnose and treat stroke and other brain injuries.

Associate Professor Shieak Tzeng says his team will use the nearly $1 million award to research and develop a device that will make it safer, cheaper, and quicker for doctors to diagnose and treat these brain injuries.

“Brain tissue is exceptionally vulnerable to ischaemia (lack of oxygen), so early detection and targeted therapy are crucial to improving survival rates across a wide range of conditions,” says Associate Professor Tzeng, Director of the Centre for Translational Physiology at UOW.

Current technologies for detecting a lack of oxygen to the brain are invasive or need costly imaging equipment which limits their use.

“This work will build on our previous research that showed our concept, based on portable magnetic resonance technology, can detect changes in levels of blood oxygen,” says Associate Professor Tzeng.

“Our goal now is to design new sensors that can detect a wider range of brain injury biomarkers, such as tissue diffusion and perfusion,” he says.

“If successful this would provide doctors with a full picture of brain injury processes so that treatments can be given in a targeted fashion.

The device will be designed and built here in New Zealand.

“We will design it in partnership with those New Zealand’s health professionals who will be using it as well as the NZ biotechnology industry to make the device accessible worldwide,” says Associate Professor Tzeng.

“We have a vision of New Zealand export sales of medical devices that enable comprehensive brain monitoring at the ‘point-of-care’” says Tzeng.

Since tissue ischaemia is the world's most common brain injury mechanism, such a versatile device may revolutionise the treatment of neurovascular disorders including stroke and traumatic brain injury.

For more information, please contact

Associate Professor Shieak Tzeng,
Director
Centre for Translational Physiology
University of Otago, Wellington
Mob: +64 27 940 7808
Email: shieak.tzeng@otago.ac.nz

A list of Otago experts available for media comment is available elsewhere on this website.

Electronic addresses (including email accounts, instant messaging services, or telephone accounts) published on this page are for the sole purpose of contact with the individuals concerned, in their capacity as officers, employees or students of the University of Otago, or their respective organisation. Publication of any such electronic address is not to be taken as consent to receive unsolicited commercial electronic messages by the address holder.